News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • NextNRG Q1 revenue rose 29% to $21.1M and adjusted EBITDA improved, though net loss widened on non‑cash stock compensation; call May 18.
  • ERock filed for a NYSE IPO, citing a $1.3bn contracted sales backlog and naming Morgan Stanley and J.P. Morgan as lead underwriters.
  • MARA completed a consent solicitation to amend Long Ridge Energy's 2032 notes, enabling a pending acquisition expected to close in H2 2026.
  • Russia's MOEX fell 0.96% as mining, power and oil stocks dragged, while the Russian volatility index rose.
  • Colombian COLCAP slipped 0.98% led by financials and public services, while Mexico's S&P/BMV IPC dropped 1.78% on industrials and consumer weakness.
  • Analysts pitched a Micron trade targeting AI-driven DRAM demand with entry $110, stop $85 and target $150 over roughly 45 trading days.

Latest Articles

UBS Sticks With Buy on AppFolio, Holds $260 Price Target After Q4 Results

UBS Sticks With Buy on AppFolio, Holds $260 Price Target After Q4 Results

UBS retained its Buy rating on AppFolio (APPF) and kept a $260.00 price target after reviewing the company’s fourth-quarter results and a subsequent management call. The bank highlighted robust unit growth and management’s positive tone as reasons for optimism, while noting that revenue may lag unit expansion as AppFolio moves upmarket. The stock i…

Truist Lifts Reddit Price Target to $275 Following Strong Q4 2025 Results

Truist Lifts Reddit Price Target to $275 Following Strong Q4 2025 Results

Truist Securities increased its price objective for Reddit to $275 from $270 and reaffirmed a Buy rating after the company posted robust fourth-quarter 2025 results. The quarter delivered 70% year-over-year revenue growth and a 43% AEBITDA margin, and the company announced a $1 billion share repurchase program. Other sell-side firms issued divergen…

Zillow Shares Jump After Judge Allows Listing Rule to Stay in Place

Zillow Shares Jump After Judge Allows Listing Rule to Stay in Place

Zillow Group's stock climbed after a federal judge refused Compass Inc.'s bid to temporarily block Zillow's rule that requires listings to be posted to a local multiple-listing service within 24 hours of being marketed elsewhere. The ruling permits Zillow to keep enforcing the policy as Compass's antitrust lawsuit, filed in June, moves forward, mar…

Morgan Stanley trims Kering target as Gucci's rebound shows early weakness

Morgan Stanley trims Kering target as Gucci's rebound shows early weakness

Morgan Stanley cut its price target on Kering to €315 from €370, citing a slower-than-expected start to 2026 for the luxury group and renewed doubts over the pace of Gucci's turnaround. The bank trimmed sales forecasts for 2026 and 2027 and said it lowered earnings estimates across the 2026-28 cycle, while keeping an Overweight rating given longer-…

Bernstein SocGen Lifts Cummins Price Target to $600 After Mixed Q4 Results

Bernstein SocGen Lifts Cummins Price Target to $600 After Mixed Q4 Results

Bernstein SocGen Group increased its price target on Cummins to $600 from $544 and kept a Market Perform rating after the engine maker's fourth-quarter results. The quarter delivered an earnings beat and slightly stronger EBITDA, but guidance that included lower margin expectations sent the stock down 11%, even as the company outlined modest sales …

Bernstein SocGen Cuts Boston Scientific Target After EP Sales Shortfall

Bernstein SocGen Cuts Boston Scientific Target After EP Sales Shortfall

Bernstein SocGen has reduced its 12-month price target for Boston Scientific to $112 from $130 but retained an Outperform rating following a weaker-than-expected quarter in U.S. electrophysiology sales. The company’s Q4 EP revenue of $606 million fell short of the $643 million consensus, coinciding with an 18% slide in the stock amid heightened inv…